Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare Limited has announced the publication of case studies authored by its research officers, managing director, consultants, and Ayurvedic experts in the 'International Journal of Advanced Research (IJAR)'. These publications highlight the company's dedication to Ayurvedic research and evidence-based clinical practices. The case studies focus on Ayurvedic management of chronic kidney disease and the role of Ayurveda in managing kidney disorders. The company has provided links to these publications and also made them available on its website, reinforcing its commitment to transparency and sharing its research findings.

Jeena Sikho Lifecare Ltd announced board resolutions from a meeting held on July 15, 2026. Key decisions include the resignation of Mrs. Smita Chaturvedi as Company Secretary and Compliance Officer, effective July 14, 2026. Ms. Priya Goyal has been appointed as the new Company Secretary and Compliance Officer, effective July 15, 2026. Additionally, Mr. Ajay Sharma and Mrs. Sapna Singh have been appointed as Additional Directors (Non-Executive Independent Category), subject to shareholder approval. Their appointments are for a tenure of two years, commencing July 15, 2026, and ending July 14, 2028.

Jeena Sikho Lifecare Limited has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut for all directors, KMPs, connected persons, designated persons, and their immediate relatives. It commences from July 1, 2026, and will remain closed until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. During this period, these individuals are prohibited from trading in the company's shares. The date for the board meeting to approve these financial results will be communicated separately.

Jeena Sikho Lifecare Limited's Board of Directors has approved the sale of land and building in Mohali, Punjab, for ₹9.05 crore to M/s VSB Enterprises. The property, measuring approximately 11 Bigha 02 Biswa 13 Biswasi, was utilized for business operations. Importantly, the company will continue to occupy and use the premises under a lease-back arrangement, ensuring no disruption to its business operations. The sale does not constitute a disposal of the company's undertaking. The transaction is with an unrelated party and is not a related party transaction. The revenue from the premises for FY26 was ₹46.47 crore (6% of total revenue), and its carrying value was ₹3.35 crore (0.72% of net worth).

Jeena Sikho Lifecare Limited has executed a Memorandum of Understanding cum Research Facility Usage Agreement to establish a dedicated Research Institute and Facility in Chandigarh. This centre will focus on research, innovation, education, and knowledge development in Ayurveda, Integrative Healthcare, Preventive Wellness, and allied disciplines. The agreement, effective from June 15, 2026, is for an initial period of five years and does not involve any rent or lease payments. The company will bear operational expenses and has the freedom to undertake renovations. This initiative aims to strengthen the company's R&D capabilities and advance evidence-based healthcare.

Jeena Sikho Lifecare Ltd announced plans to establish a new hospital facility in Lucknow, Uttar Pradesh. The facility, expected to commence operations by August 2026, will have an estimated area of 1.25 lakh sq. ft. and a capacity of over 160 beds. The estimated investment for this expansion is approximately ₹3 Crores, which will be financed through the company's internal funds. This move aligns with the company's strategic objective to broaden its healthcare network and extend its quality Panchakarma services to a wider population.

Jeena Sikho Lifecare Ltd announced plans to establish a new Day Care Clinic in Ayodhya, Uttar Pradesh. The clinic, with an estimated area of 2300 sq. ft., is expected to commence operations by August 2026. This expansion is part of the company's strategy to broaden its healthcare network and enhance its Panchakarma services. The estimated investment for this new facility is approximately Rs. 50 Lakhs, which will be financed through the company's internal funds.

Jeena Sikho Lifecare Limited has commenced operations of its new hospital facility in Mathura, Uttar Pradesh, effective June 10, 2026. This 100-bed facility, named Sanskriti Ayurvedic P.G. Medical College & Hospital, spans approximately 60,000 sq. ft. and includes 8 OPDs. The expansion aligns with the company's strategy to enhance its healthcare infrastructure and broaden access to Ayurvedic services across India. This development is expected to contribute to the company's growth and strengthen its regional presence.

Jeena Sikho Lifecare Limited has announced the receipt of the National Accreditation Board for Hospitals & Healthcare Providers (NABH) Certificate of Accreditation for its hospital located in Bhopal, Madhya Pradesh. The accreditation is valid until May 04, 2029. This signifies the hospital's adherence to high standards of quality healthcare delivery, patient safety, and operational excellence. The company clarified that this accreditation is an outcome of normal business operations and does not represent business expansion, capacity enhancement, or an acquisition.

Jeena Sikho Lifecare Ltd's board has recommended a final dividend of ₹4.50 per equity share (face value of ₹2 each) for the financial year 2025-26, subject to shareholder approval. The board also approved the audited financial results for the quarter and year ended March 31, 2026, and re-appointed M/s Forvis Mazars LLP as the Internal Auditor for FY 2026-27. The decisions were made at a board meeting held on May 30, 2026.